Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 12:38 PM GMTBristol asked the Delaware court for an undisclosed amount of monetary damages.
Delhi HC restrains Micro Lab from infringing Bristol Myers anticoagulant drug Apixaban Medical Dialogues Team19 Aug 2021 11:37 AM GMTNew Delhi: The Delhi High Court has passed an ex-parte ad- interim injunction restraining Micro Labs Limited from infringing any generic Apixaban...
Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk - study Medical Dialogues Team21 Sep 2020 7:15 AM GMTNEW YORK: Bristol Myers Squibb Co's cancer immunotherapy Opdivo in combination with Exelixis Inc's Cabometyx reduced the risk of death by 40% in...
Bristol Myers Squibb Onureg gets USFDA approval to treat Acute Myeloid Leukemia Medical Dialogues Bureau12 Sep 2020 3:45 AM GMTPrinceton: Bristol Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets,...
FDA declines expanded approval for Bristol-Myers' Opdivo drug Pooja Bhatia Bhatia28 Nov 2015 4:26 AM GMTBristol-Myers Squibb Co said the U.S. Food and Drug Administration declined to approve its immuno-oncology drug, Opdivo, for its expanded use to treat...
